South Florida Research Organization LLC

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Atrial fibrillation3 trials
• Stroke3 trials
• Chronic kidney disease1 trial
• Coronary artery disease1 trial
• Peripheral artery disease1 trial

Phase

• Phase 32 trials
• Phase 21 trial
• Phase 2/31 trial

Status

• Recruiting4 trials

Lead sponsor

• Regeneron Pharmaceuticals3 trials
• CSL Behring1 trial

Running trials

• Recruiting

  Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  NCT07626411· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Recruiting

  Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

  NCT07430956· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Recruiting

  Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

  NCT07175428· Phase 2· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Recruiting

  Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  NCT05485961· Phase 2/3· CSL Behring· Source

  Contact: Trial Registration Coordinator

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation3 recruiting
• Stroke3 recruiting
• Chronic kidney disease1 recruiting
• Coronary artery disease1 recruiting
• Peripheral artery disease1 recruiting